PALDINO, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 4.125
AS - Asia 2.982
EU - Europa 2.647
SA - Sud America 367
Continente sconosciuto - Info sul continente non disponibili 278
AF - Africa 107
OC - Oceania 10
Totale 10.516
Nazione #
US - Stati Uniti d'America 3.986
SG - Singapore 1.063
IT - Italia 956
CN - Cina 674
DE - Germania 330
VN - Vietnam 297
BR - Brasile 266
HK - Hong Kong 247
BD - Bangladesh 240
PL - Polonia 215
NL - Olanda 189
KR - Corea 175
SE - Svezia 167
GB - Regno Unito 149
FR - Francia 148
FI - Finlandia 133
RU - Federazione Russa 89
CA - Canada 82
IN - India 71
IE - Irlanda 56
BG - Bulgaria 47
CH - Svizzera 40
AR - Argentina 36
MA - Marocco 32
TR - Turchia 31
ID - Indonesia 29
ES - Italia 28
JP - Giappone 25
MX - Messico 24
ZA - Sudafrica 23
UA - Ucraina 21
EG - Egitto 19
IQ - Iraq 19
AT - Austria 18
CO - Colombia 15
EC - Ecuador 14
CL - Cile 13
PK - Pakistan 12
SA - Arabia Saudita 12
AE - Emirati Arabi Uniti 10
CZ - Repubblica Ceca 10
PH - Filippine 10
PY - Paraguay 9
AU - Australia 8
CR - Costa Rica 8
IR - Iran 8
TW - Taiwan 8
VE - Venezuela 8
BE - Belgio 7
KE - Kenya 6
TH - Thailandia 6
GR - Grecia 5
KZ - Kazakistan 5
LT - Lituania 5
HN - Honduras 4
JO - Giordania 4
LB - Libano 4
NP - Nepal 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
UY - Uruguay 4
AL - Albania 3
AO - Angola 3
AZ - Azerbaigian 3
BY - Bielorussia 3
CY - Cipro 3
JM - Giamaica 3
KG - Kirghizistan 3
LV - Lettonia 3
MY - Malesia 3
NG - Nigeria 3
NO - Norvegia 3
PT - Portogallo 3
UZ - Uzbekistan 3
AM - Armenia 2
BO - Bolivia 2
BW - Botswana 2
BZ - Belize 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GA - Gabon 2
GD - Grenada 2
IL - Israele 2
KW - Kuwait 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
AG - Antigua e Barbuda 1
AI - Anguilla 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
Totale 10.216
Città #
Singapore 633
Ashburn 587
San Jose 331
Hong Kong 225
Council Bluffs 220
Chandler 216
Dallas 194
Beijing 171
Trieste 171
Warsaw 162
Hefei 160
Seoul 160
Fairfield 142
Los Angeles 141
Munich 138
Chicago 116
Milan 98
Ho Chi Minh City 91
Helsinki 85
Seattle 84
Columbus 81
Boardman 80
Santa Clara 78
New York 75
Hanoi 64
London 64
Woodbridge 61
Cambridge 58
Lauterbourg 55
Wilmington 53
Dublin 51
Amsterdam 48
Frankfurt am Main 47
Sofia 46
Zgierz 45
Princeton 44
Houston 42
Buffalo 39
Moscow 35
Rome 34
Orem 30
Phoenix 30
Venice 30
Da Nang 27
Lappeenranta 27
São Paulo 27
Florence 26
Denver 25
Casablanca 24
Ann Arbor 23
Naples 23
Nuremberg 23
Bern 21
Brooklyn 21
Redondo Beach 20
Bologna 18
Memphis 18
Montreal 18
San Diego 18
Shanghai 17
Toronto 17
Washington 17
Bremen 16
Chennai 16
Salt Lake City 16
Turin 16
Atlanta 15
Boydton 15
Düsseldorf 15
Vienna 15
Jacksonville 14
Tokyo 14
Turku 14
Elk Grove Village 13
Izmir 13
Münster 13
Stockholm 13
Tampa 13
The Dalles 13
Dong Ket 12
Grafing 12
San Francisco 12
Berlin 11
Boston 11
Dearborn 11
Dhaka 11
Haiphong 11
Bari 10
Charlotte 10
Genoa 10
Giza 10
Paris 10
Redmond 9
Baghdad 8
Breda 8
Brescia 8
Istanbul 8
Jeddah 8
Johannesburg 8
Las Vegas 8
Totale 6.175
Nome #
High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients 322
Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction 300
Hot Phases Cardiomyopathy: Pathophysiology, Diagnostic Challenges, and Emerging Therapies 286
Chapter 13: Current Management and Treatment 278
Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome-There is Meat on the Bone 260
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 256
Genetics of Dilated Cardiomyopathy: Clinical Implications 252
TITIN DOWNREGULATION AFFECTS CARDIOMYOCYTES PROLIFERATION 249
Global longitudinal strain by CMR improves prognostic stratification in acute myocarditis presenting with normal LVEF 248
Phenotypic Expression, Natural History and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants 240
Genetic and Phenotypic Characterization of Nexilin (NEXN)-Related Cardiomyopathy: Results From a Multicentric Study 234
Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers 233
Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction 233
ICD replacement in patients with intermediate left ventricular dysfunction under optimal medical treatment 232
Association of Titin Variations with Late-Onset Dilated Cardiomyopathy 225
Prevalence and evolution of right ventricular dysfunction among different genetic backgrounds in dilated cardiomyopathy 224
Strain analysis reveals subtle systolic dysfunction in confirmed and suspected myocarditis with normal LVEF. A cardiac magnetic resonance study 210
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy 208
Echocardiographic evaluation of centenarians in Trieste 206
Apoptosis, a useful marker in the management of hot-phase cardiomyopathy? 199
Current diagnostic strategies for dilated cardiomyopathy: a comparison of imaging techniques 197
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy 193
Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy 182
Myocarditis: Which Role for Genetics? 180
Cardiomyopathies in children: Classification, diagnosis and treatment 179
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants 178
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies 173
Prognostic role of exercise intensity in familial Filamin C truncating variants 167
The response to cardiac resynchronization therapy in LMNA cardiomyopathy 166
Critical analysis of the 2023 ESC guidelines on cardiomyopathy management 160
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 159
Cardiology of the future: xenotransplantation with porcine heart 157
Lymphocytic Myocarditis: A Genetically Predisposed Disease? 149
Prognostic value of echocardiographic evaluation of cardiac mechanics in patients with aortic stenosis and preserved left ventricular ejection fraction 148
Genetic testing in cardiomyopathies: updates and future perspectives 146
SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study 145
Focus on arrhythmogenic right ventricular cardiomyopathy 145
Whole-exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases 139
Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function 139
Generation of human induced pluripotent stem cell line EURACi015-A from a patient affected by dilated cardiomyopathy carrying the Lamin A/C p.Glu161Lys mutation 137
Generation of iPSC lines (ICHi001-A, ICHi002-A, ICHi003-A, ICHi004-A) from four patients carrying Titin truncating variants associated with dilated cardiomyopathy 137
Subclinical systolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients: A systematic review and meta-analysis 136
Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score 134
Exercise Intensity and Cardiac Disease Development in carriers of Titin variants 133
SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence 133
Sport and Exercise in Genotype positive (+) Phenotype negative (-) Individuals. Current Dilemmas and Future Perspectives 131
Fenotypic expressions and clinical manifestations of arrhythmogenic cardiomyopathy 124
Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy 122
New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy 118
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function 114
Titin-related familial dilated cardiomyopathy: factors associated with disease onset 112
The contribution of cardiopulmonary exercise testing in the familial screening for dilated and non-dilated left ventricular cardiomyopathies: case series 106
Clustering in dilated cardiomyopathy at initial evaluation: An effective tool for clinical stratification 100
Prediction and prognostic role of left ventricular systolic dysfunction in family screening for dilated cardiomyopathy and non-dilated left ventricular cardiomyopathy 99
Titin Cardiomyopathy, Emerging Evidence: More Than A Big Heart 98
Impact of genotype-phenotype associations on prognosis in dilated cardiomyopathy 80
Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy 74
Reply to the letter regarding the article 'Subclinical systolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients: A systematic review and meta-analysis' 68
Pregnancy in patients with inherited myocardial disorders – A consensus document on preconception counseling and pregnancy management by the working group on myocardial and pericardial disorders of the Italian Society of Cardiology 62
Predictors of Disease Progression in Patients with Left Ventricular Non-Dilated Cardiomyopathy 58
External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variants 47
What Should a Clinical Cardiologist Know About Cardiogenetics? 43
Twenty-Five-Year Follow-Up of the MDDC1 Family: A LMNA Gene Variant Associated With Dilated Cardiomyopathy With Variable Skeletal Muscle Involvement 34
Red Flags for Differentiating Desmosomal "Hot-Phase" Cardiomyopathy From Acute Myocarditis 28
Significance of common genetic variants associated with non-ischaemic cardiomyopathy in the general population 25
RBM20 Truncating Variants and Human Cardiomyopathy 23
Arrhythmic Risk in Carriers of Predicted Deleterious Rare Variants in Dilated and Arrhythmogenic Cardiomyopathy Genes 19
Polygenic risk in early-onset coronary artery disease with low prevalence of traditional cardiovascular risk factors 17
Variant Site-Specific Natural History of Titin-Induced Cardiomyopathy: An International Multicenter Registry 7
Totale 10.516
Categoria #
all - tutte 30.539
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.539


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022318 0 0 62 15 12 30 13 12 35 20 31 88
2022/2023572 39 80 55 86 63 92 4 46 50 10 37 10
2023/2024653 45 23 36 37 46 66 114 80 20 37 88 61
2024/20251.882 52 77 149 123 134 152 142 146 244 262 173 228
2025/20265.393 455 349 612 471 403 376 636 208 484 583 546 270
2026/2027857 313 372 172 0 0 0 0 0 0 0 0 0
Totale 10.516